<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00250328</url>
  </required_header>
  <id_info>
    <org_study_id>HMO-CLP 52-01- HMO-CTIL</org_study_id>
    <nct_id>NCT00250328</nct_id>
  </id_info>
  <brief_title>Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy</brief_title>
  <official_title>Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <brief_summary>
    <textblock>
      The study involves adult subject requiring colonic anastomosis following laparoscopic&#xD;
      intra-corporeal surgery. The anastomosis will be performed by using nitinilclip by the LapCAC&#xD;
      device instead of staplers.&#xD;
&#xD;
      Endpoints: safety-Functioning secured anastomosis and no occurrence of adverse event related&#xD;
      to device use.&#xD;
&#xD;
      The efficacy endpoint of this study includes clinical evaluation of characteristic parameters&#xD;
      related to intestinal surgeries.&#xD;
&#xD;
      Discharge day (or ready-for-discharge) Proven anastomotic leak rate (clinically or&#xD;
      radiological) Stenosis / stricture at anastomosis Patient recovery level will be assessed&#xD;
      every day during hospitalization and in the follow up visits.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following steps are to be performed during the NiTi LapCAC surgical procedure.&#xD;
&#xD;
        1. Prophylactic antibiotic - as per specific department regimen.&#xD;
&#xD;
        2. Bowel preparation will be performed one-day prior to surgery. The preparation will&#xD;
           included Sofodex solution combined with oral neomycin.&#xD;
&#xD;
        3. Aanticoagulation tratment prior surgery- as per specific department regimen.&#xD;
&#xD;
        4. Routine general anesthesia according to standard operation room procedure.&#xD;
&#xD;
        5. Prepare the surgery area according to routine procedure with soap and alcohol. Insert&#xD;
           the trocars.&#xD;
&#xD;
        6. Align the two ends of bowel side-by-side in the same direction or in the opposite&#xD;
           direction. Seal the ends with staples leaving blind loop of no less than 2.5 cm. (1&#xD;
           inch) and make two small enterotomies.&#xD;
&#xD;
        7. The Clip mounted on the Applier should be cooled by immersing it in ice-cold sterile&#xD;
           saline bath for at least 20 seconds.&#xD;
&#xD;
        8. Place the open clip into the prepared enterotomies, each clip coil in one enterotomy.&#xD;
&#xD;
        9. Approximating body temperature, the coils will recover its programmed shape applying&#xD;
           pressure on the tissue.&#xD;
&#xD;
       10. Closure (staple line and enterotomies): closure of the enterotomies with or without&#xD;
           suture inversion of staple lines will be done by using Vicryl suture 3-0 or other&#xD;
           absorbable suture. Postoperative care will be as for conventional treatment.&#xD;
&#xD;
       11. Post operative treatment will be according to the department regimen and in relation to&#xD;
           the patient condition.&#xD;
&#xD;
      The following baseline variables will be recorded for all patients:&#xD;
&#xD;
        1. Demographics, including: gender, age, race, weight and height (BMI), ASA status.&#xD;
&#xD;
        2. Background of disease - presentation, and TNM stage, etc.&#xD;
&#xD;
        3. Region of excised colon.&#xD;
&#xD;
        4. Metastasis yes/no where.&#xD;
&#xD;
        5. Co-morbidities:&#xD;
&#xD;
           Cardiac- (Ischemic heart disease (IHD), Congestive heart failure (CHF), NYHA&#xD;
           Classification I,II,III,IV).&#xD;
&#xD;
           Respiratory- Asthma, Obstructive pulmonary disease (OPD). Diabetes- Type&#xD;
           1(insulin-dependent diabetes), Type 2 (non-insulin-dependent diabetes).&#xD;
&#xD;
           hepatic- Cirrhosis. Alcohol Smoking.&#xD;
&#xD;
        6. Medications.&#xD;
&#xD;
      Follow-up evaluation will be performed every day during hospitalization and one-month, three&#xD;
      months and six months post procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functioning anastomosis without leaks or obstructions</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functioning anastomosis without stenosis</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Colon Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LapCAC Laparoscopic Compression Anastomosis Clip</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient age over 18 years.&#xD;
&#xD;
          2. Patient schedule for colonic surgery which requires a bowel anastomosis (right colon,&#xD;
             left colon, sigma).&#xD;
&#xD;
          3. Patient is able to understand and to sign the Informed Consent Form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient has known allergy to nickel.&#xD;
&#xD;
          2. Emergency procedure, i.e. patients with bowel obstruction, bowel strangulation,&#xD;
             peritonitis, bowel perforation, local or systemic infection, ischaemic bowel,&#xD;
             carcinomatosis.&#xD;
&#xD;
          3. Patients with Crohn's disease needed more than one anastomosis.&#xD;
&#xD;
          4. Patient underwent previous major abdominal surgery.&#xD;
&#xD;
          5. Patients under steroid treatment.&#xD;
&#xD;
          6. Patient albumin level less than 3 g/dl&#xD;
&#xD;
          7. Patients under immuno-suppression or cytotoxic treatment.&#xD;
&#xD;
          8. Patients who are participating in another trial which may affect the outcomes data on&#xD;
             this study.&#xD;
&#xD;
          9. Patients with contraindications to general anaesthesia.&#xD;
&#xD;
         10. Patients who refuse consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Matter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benei-Zion Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ibrahim Matter, MD</last_name>
    <phone>04-8359137</phone>
    <email>matardoc@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization, Jerusalem, Israel</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Arik Tzukert,, DMD</last_name>
      <phone>00 972 2 6776095</phone>
      <email>arik@hadassah.org.il</email>
    </contact>
    <contact_backup>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>00 972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact_backup>
    <investigator>
      <last_name>Nacum Beglibter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2005</verification_date>
  <study_first_submitted>November 6, 2005</study_first_submitted>
  <study_first_submitted_qc>November 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2005</study_first_posted>
  <last_update_submitted>November 6, 2005</last_update_submitted>
  <last_update_submitted_qc>November 6, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 8, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

